|
Divi's Laboratories (ICICI securities) Revival on cards |
|
divi's lab (Emkay) Strong quarter; Upgrade estimates - Maintain Buy |
|
divi's lab (Emkay) Growth momentum to accelerate; Upgrade to Buy |
|
divi's lab (emkay) Strong quarter; Maintain Accumulate |
|
divi's lab (MerrillLynchBofA) |
| Date |
Rating |
Target Price |
Recommendation Price |
Broker house |
| 14 Dec 2010 |
po |
716 |
-- |
MerrillLynchBofA Report |
Yahoo Link+NSE Link+Reuters Link+Reuters India Link+Google Link+DSR Search Link
Reports.DesiStockResearch.com |
|
Divi’S Lab (emkay) Below expectations; Downgrade to Accumulate |
|
divi's lab (Karvy) Sales lower, 2HFY11 expected to be positive |
|
Divis Labora (MotilalOswal ) |
|
Divi’S Lab (MerrillLynchBofA) |
| Date |
Rating |
Target Price |
Recommendation Price |
Broker house |
| 9 Nov 2010 |
PO |
815 |
- |
MerrillLynchBofA Report |
Yahoo Link+NSE Link+Reuters Link+Reuters India Link+Google Link+DSR Search Link
Reports.DesiStockResearch.com |
|
Divis Laboratory (MotilalOswal ) |
